CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities
Net loss	$ (1,311,259)	$ (443,073)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for employee advance reserve		2,143
Depreciation and amortization	125,148	138,157
Stock-based compensation	213,860	258,114
Gain on settlement of accounts payable	(55,432)	(105,764)
Amortization of debt discount	13,778	98,134
Changes in operating assets and liabilities:
Accounts receivable	(6,107)	20,898
Inventories - finished goods	(35,045)	(28,458)
Prepaid expenses and other current assets	(23,370)	(32,768)
Accounts payable - trade	480,921	(167,259)
Accounts payable - related parties	(862)	(44,314)
Accrued expenses and other current liabilities	370,757	(98,618)
Deferred revenue		(5,017)
Net cash used in operating activities	(227,611)	(407,825)
Cash flows from investing activities
Change in restricted cash	(16,704)	36,077
Capital expenditures	(3,648)	(5,539)
Website development costs		(18,125)
Net cash (used in) provided by investing activities	(20,352)	12,413
Cash flows from financing activities
Principal payments on equipment leases payable	(46,143)	(47,665)
Proceeds from exercise of common stock options	1,817
Proceeds from issuance of notes payable	308,911
Repayment of notes payable - related parties	(23,889)	(37,700)
Net cash provided by (used in) financing activities	240,696	(85,365)
Net decrease in cash	(7,267)	(480,777)
Cash - beginning of period	11,217	506,019
Cash - end of period	3,950	25,242
Cash paid for:
Interest	69,870	58,416
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	319,854	298,918
Warrants issued as debt discount in connection with notes payable	15,500	41,300
Accrual of contractual dividends on Series B convertible preferred stock	256,675	239,882
Cashless exercise of common stock purchase warrants	2,647
Conversion of accounts payable to common stock	$ 698,594